KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
1.050
+0.125 (13.51%)
At close: Dec 4, 2025, 4:00 PM EST
0.9910
+0.0270 (2.80%)
Pre-market: Dec 5, 2025, 7:05 AM EST
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $8.62 million as of December 5, 2025. Its market cap has decreased by -71.64% in one year.
Market Cap
8.62M
Enterprise Value
16.76M
1-Year Change
-71.64%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $8.62M, a decrease of -98.00%. That is a compound annual growth rate of -37.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 7.90M | -75.31% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |